Bibliographic citations
López, L., (2022). Actividad del zumo de Sanky (Corryocactus brevistylus) sobre marcadores bioquímicos de riesgo cardiovascular en ratas con hiperlipidemia inducida experimentalmente [Universidad Nacional Agraria La Molina]. https://hdl.handle.net/20.500.12996/5188
López, L., Actividad del zumo de Sanky (Corryocactus brevistylus) sobre marcadores bioquímicos de riesgo cardiovascular en ratas con hiperlipidemia inducida experimentalmente []. PE: Universidad Nacional Agraria La Molina; 2022. https://hdl.handle.net/20.500.12996/5188
@mastersthesis{renati/1116053,
title = "Actividad del zumo de Sanky (Corryocactus brevistylus) sobre marcadores bioquímicos de riesgo cardiovascular en ratas con hiperlipidemia inducida experimentalmente",
author = "López Arisaca, Lizbeth Carolina",
publisher = "Universidad Nacional Agraria La Molina",
year = "2022"
}
The objective of the present study was to evaluate the effect of sanky (Corryocactus brevistylus) juice on biochemical markers of cardiovascular risks in rats with experimentally induced hyperlipidemia. Twenty-eight rats, randomly distributed in four groups with seven repetitions each, were used. Each experimental group received, for 30 days, one of the following treatments: T1, Obesogenic diet (OD); T2, OD + Lovastatin (0.5 mg/kg/day); T3, OD + Sanky juice (5 ml/kg/day) and T4, OD + Sanky juice (10 ml/kg/day). Both lovastatin and sanky juice were orogastrically administered. During the trial, initial and final live weight, weight gain and feed intake were recorded. Then, at the end of the experimental period, blood samples were collected from each animal for glucose, triglycerides and C-HDD determinations. The recorded data were subjected to ANOVA under a Completely Randomized Design and the comparison of means was performed through Tukey's test, using the MINITAB 18 statistical software. The results showed that live weight, weight gain and feed intake were influenced (p>0.05) by the dietary treatments. However, the animals that received Treatment 4 (T4) showed the lowest and the highest (p<0.05) triglycerides and HDL levels, respectively, compared to those of the other treatments; likewise, it tended to decrease the blood glucose level. In conclusion, Sanky juice, at the level of 10 ml/kg/d, has a greater hypolipidemic effect than the commercial drug evaluated.
This item is licensed under a Creative Commons License